Exosome-shuttling MicroRNA-21 Promotes Cell Migration and Invasion-targeting PDCD4 in Esophageal Cancer
Overview
Authors
Affiliations
Recent evidence indicates that exosomes can mediate certain microRNAs (miRNAs) involved in a series of biological functions in tumor occurrence and development. Our previous studies showed that microRNA-21 (miR-21) was abundant in both esophageal cancer cells and their corresponding exosomes. The present study explored the function of exosome-shuttling miR-21 involved in esophageal cancer progression. We found that exosomes could be internalized from the extracellular space to the cytoplasm. The exosome-derived Cy3-labeled miR-21 mimics could be transported into recipient cells in a neutral sphingomyelinase 2 (nSMase2)-dependent manner. miR-21 overexpression from donor cells significantly promoted the migration and invasion of recipient cells by targeting programmed cell death 4 (PDCD4) and activating its downstream c-Jun N-terminal kinase (JNK) signaling pathway after co-cultivation. Our population plasma sample analysis indicated that miR-21 was upregulated significantly in plasma from esophageal cancer patients and showed a significant risk association for esophageal cancer. Our data demonstrated that a close correlation existed between exosome-shuttling miR-21 and esophageal cancer recurrence and distant metastasis. Thus, exosome-shuttling miR-21 may become a potential biomarker for prognosis among esophageal cancer patients.
Macrophage-derived lncRNAs in cancer: regulators of tumor progression and therapeutic targets.
Suliman M, Saleh R, Chandra M, Rasool K, Jabir M, Jawad S Med Oncol. 2025; 42(4):91.
PMID: 40048034 DOI: 10.1007/s12032-025-02643-2.
Relationship between exosomes and cancer: formation, diagnosis, and treatment.
Huang C, Li J, Xie Z, Hu X, Huang Y Int J Biol Sci. 2025; 21(1):40-62.
PMID: 39744442 PMC: 11667803. DOI: 10.7150/ijbs.95763.
Exosomes in esophageal cancer: function and therapeutic prospects.
Wang C, Shi Z Med Oncol. 2024; 42(1):18.
PMID: 39601925 DOI: 10.1007/s12032-024-02543-x.
Zabeti Touchaei A, Norollahi S, Najafizadeh A, Babaei K, Bakhshalipour E, Vahidi S Cancer Cell Int. 2024; 24(1):334.
PMID: 39369258 PMC: 11453077. DOI: 10.1186/s12935-024-03514-y.
DAntonio C, Liguori G Front Immunol. 2024; 15:1441914.
PMID: 39301024 PMC: 11410588. DOI: 10.3389/fimmu.2024.1441914.